Maraviroc (brand-named Selzentry, or Celsentri outside the U.S.) is a drug used in the treatment of HIV infection. Developed in SW where all the good people work. Approved by the FDA in 2007.

correct; in real terms, inclusive of lay-offs and restructuring, the actual arithmetic equates to just under 3 billion/year in research cuts. But thats Pfizer, why let the truth get in the way of good bullshit.

Cut will be $3B not $1B.

Duh...Management Science. The managers are the core of our great company.

"What makes you think that "science" was going on at Pfizer?"

when was last time Pfizer R&D found a real drug?

What makes you think that "science" was going on at Pfizer?

Can someone tell me how the United States can remain a scientific superpower when things like this go on?

I know that the CEO of Pfizer is a lawyer and not a scientist, but shouldn't he have more foresight than this?

Yes, but you do realize that Pfizer is big enough to 'buy' those new drugs versus R&D'ing them! The rumor that we hear around the New London campus is that we (PFE) is turning into one big, fat marketing company...

Have you noticed all of the 'joint ventures' being created? A partnership with this company and with that company...?

By 2012, Pfizer will be the company to go to for selling drugs - not for researching, developing and manufacturing!

Not from their own internal R+D they don't

"Pfizer had announced it expected to reduce its R&D costs by about $1 billion in 2012. While that may save the company cash it is a big risk — drug companies only make money if they can find new drugs, and R&D is where new drugs come from."